<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Health / Pharmaceutical industry / Pharmacology / European Medicines Agency / European Union / Marketing authorization / European Directorate for the Quality of Medicines / EudraLex / European Pharmacopoeia / Orphan drug / Supplementary protection certificate
Date: 2015-07-08 04:50:21
Pharmaceuticals policy
Health
Pharmaceutical industry
Pharmacology
European Medicines Agency
European Union
Marketing authorization
European Directorate for the Quality of Medicines
EudraLex
European Pharmacopoeia
Orphan drug
Supplementary protection certificate

emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 535,20 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document